Cue Biopharma's total assets for Q2 2024 were $42.33M, a decrease of -21.54% from the previous quarter. CUE total liabilities were $20.71M for the fiscal quarter, a -13.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.